智通财经APP讯,和黄医药(00013)发布公告,将于2025年10月31日(星期五)在中国上海举办会议分享最新研发进展,并将通过网络同步直播。
活动期间,和黄医药执行副总裁、研发负责人兼首席医学官石明博士将分享公司的研发策略和愿景,包括概述公司抗体靶向偶联药物(ATTC)平台并重点介绍其首个候选药物HMPL-A251,以及后期研发管线的最新进展。
智通财经APP讯,和黄医药(00013)发布公告,将于2025年10月31日(星期五)在中国上海举办会议分享最新研发进展,并将通过网络同步直播。
活动期间,和黄医药执行副总裁、研发负责人兼首席医学官石明博士将分享公司的研发策略和愿景,包括概述公司抗体靶向偶联药物(ATTC)平台并重点介绍其首个候选药物HMPL-A251,以及后期研发管线的最新进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.